Search

Byline: Cara McGoogan The Infected Blood Inquiry will today release the results of its five-year investigation into the worst treatment disaster in the history of the NHS. The report is [...]

TAINAN, Taiwan, Aug. 3, 2022 /PRNewswire/ -- When the body's immune system turns on itself and attacks the body's healthy cells and organs, we develop autoimmune disorders. A rare entrant [...]

2022 SEP 21 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- Investigators publish new report on COVID-19. According to news reporting from Mantua, Italy, by NewsRx [...]

SAN DIEGO: Shareholder rights law firm Robbins LLP is investigating Generation Bio Co. (NASDAQ: GBIO) to determine whether certain Generation Bio officers and directors violated the Securities Exchange Act of [...]

SAN DIEGO -- Shareholder rights law firm Robbins LLP is investigating Generation Bio Co. (NASDAQ: GBIO) to determine whether certain Generation Bio officers and directors violated the Securities Exchange Act [...]

New York: Pomerantz LLP has issued the following news release: Pomerantz LLP is investigating claims on behalf of investors of uniQure N.V. ('uniQure' or the 'Company') (NASDAQ: QURE). Such investors [...]

NEW YORK, Dec. 23, 2020 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of uniQure N.V. ('uniQure' or the 'Company') (NASDAQ: QURE). Such investors are advised to [...]

Witness statements given to the contaminated blood scandal inquiry are 'harrowing' and 'incredibly moving', a former high court judge has said. Sir Brian Langstaff promised the probe would be 'frightened [...]

Byline: Owen Bowcott The inquiry into the contaminated blood scandal in the NHS, which is estimated to have killed more than 2,000 people since the 1970s, will open in London [...]

London: European Medicine Agency has issued the following new product details: Reference number EMA/CHMP/BPWP/144533/2009 Rev. 2 Published 13/08/2018 Effective from 01/02/2019 Keywords Recombinant factor VIII, plasma-derived factor VIII, efficacy, safety, [...]

NEW YORK: Bronstein, Gewirtz & Grossman, LLC has issued the following news release: Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Catalyst Biosciences, Inc. [...]

NEW YORK: Pomerantz LLP has issued the following news release: Pomerantz LLP is investigating claims on behalf of investors of Catalyst Biosciences, Inc. ('Catalyst' or the 'Company') (NASDAQ: CBIO). Such [...]

NEW YORK, June 18, 2018 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Catalyst Biosciences, Inc. ('Catalyst' or the 'Company') (NASDAQ: CBIO). Such investors are advised [...]

NEW YORK, June 18, 2018 Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Catalyst Biosciences, Inc. ('Catalyst' or the 'Company) (NASDAQ: [...]

NEW YORK -- Levi & Korsinsky announces it has commenced an investigation of Alnylam Pharmaceuticals, Inc. ('Alnylam' or the 'Company') (NASDAQ:ALNY) concerning possible violations of federal securities laws. On September [...]

NEW YORK, Sept. 7, 2017 /PRNewswire/ -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Alnylam Pharmaceuticals, Inc. ('Alnylam' or the 'Company') (NASDAQ: [...]

NEW YORK, Sept. 7, 2017 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Alnylam Pharmaceuticals, Inc. ('Alnylam' or the 'Company') (NASDAQ: ALNY). Such investors are advised [...]

NEW YORK -- Levi & Korsinsky announces it has commenced an investigation of Dimension Therapeutics, Inc. (NASDAQ:DMTX) concerning possible violations of federal securities laws. On January 31, 2017, Dimension announced [...]

Byline: Carly Helfand Baxter (http://www.fiercepharma.com/tags/baxter ) said back in March that Novo Nordisk's (http://www.fiercepharma.com/tags/novo-nordisk ) recently launched hemophilia med infringed some of its patents, which this week spurred an investigation [...]

- Individualized and weekly prophylactic regimens resulted in low single-digit median annualized bleeding rates - - 98% of bleeding episodes were controlled with one or two injections of rFVIIIFc - [...]

-- Prophylactic regimens resulted in low single-digit annualized bleeding rates -- -- Median dosing interval was 14 days in the individualized interval prophylaxis arm during the last 6 months on [...]

Two years after minor French officials were jailed for knowingly distributing blood contaminated with H.I.V., the scandal reached a political level today when a former Prime Minister was placed under […]

Halifax NS -- Canadian Press HALIFAX The Nova Scotia Red Cross sent possibly HIV-contaminated blood products to hospitals in 1985 while safe products sat on its shelves, a federal inquiry [...]

Regina SK -- Canadian Press REGINA A woman whose 13-year-old son died after receiving contaminated blood is comparing the doctors and health officials responsible for Canada's blood system to Nazi [...]